BioCentury
ARTICLE | Company News

UCSF taps Selick for BD position

April 25, 2017 10:54 PM UTC

The University of California San Francisco named Barry Selick vice chancellor for business development, innovation and partnerships. Selick resigned last month as CEO of Threshold Pharmaceuticals Inc. (NASDAQ:THLD).

The university said Selick will oversee proof-of-concept studies to determine which therapies, diagnostics or software are most likely to help patients. He will also lead UCSF's Industry Alliances and Program Management, Office of Technology Management, Catalyst Program, and its Entrepreneurship Center. ...